Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2025-12-24 @ 5:47 PM
NCT ID:
NCT04564768
Eligibility Criteria:
Inclusion Criteria:
* ≥ 18 years
* Being a woman
* Being diagnosed with breast or any gynecological cancer (either ovarian, cervical, vulvar, womb or vaginal cancer), stages I to IV.
* For women with localized cancers: having completed all adjuvant treatments, such as surgery, chemotherapy and/or radiotherapy, at least 3 months previously, with the exception of hormonal, immune and targeted therapy,
* For women with metastatic cancers: having a performance status \< 3, not undergoing IV chemotherapy and having a life expectancy more than 9 months as estimated by their treating oncologist.
* Free from acute infection for 2 weeks before biochemical assessment.
* Speaking and reading French fluently
* Be able to follow the online course via a computer/tablet
Exclusion Criteria:
* Inability to follow the procedures of the study due to:
* Significant deafness
* Physical impairment that prevents attending the sessions
* Mental retardation (ICD-10)
* Dementia (ICD-10)
* Depression (ICD-10) \*
* Spectrum disorder of schizophrenia (ICD-10) \*\*
* Alcohol or other substance dependence (ICD-10) \*\*
* Emotionally labile personality disorder that is incompatible with group participation (ICD-10) \*\*
* A post-traumatic stress disorder (PTSD) (ICD-10)\*\*
* Currently engages in meditation one or more times per week
* Previous participation in an MBI program
* Serious physiological illnesses that would interfere with the interpretation of biochemical data (e.g., anemia, diabetes, cardiovascular diseases, blood cancers, inflammatory bowel diseases, autoimmune diseases, asthma being treated with steroids, immunodeficiency)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04564768
Study Brief:
Protocol Section:
NCT04564768